Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2

Breast cancer: A protein to target for double effect A new way to treat some forms of breast cancer might be achieved by drugs that interact with a cell surface protein that binds to growth hormone and transmits growth-inducing signals into the cells. Rajkumar Lakshmanaswamy and colleagues at Texas...

Full description

Bibliographic Details
Main Authors: Arunkumar Arumugam, Ramadevi Subramani, Sushmita Bose Nandy, Daniel Terreros, Alok Kumar Dwivedi, Edward Saltzstein, Rajkumar Lakshmanaswamy
Format: Article
Language:English
Published: Nature Publishing Group 2019-01-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-018-0197-8
_version_ 1818857424666230784
author Arunkumar Arumugam
Ramadevi Subramani
Sushmita Bose Nandy
Daniel Terreros
Alok Kumar Dwivedi
Edward Saltzstein
Rajkumar Lakshmanaswamy
author_facet Arunkumar Arumugam
Ramadevi Subramani
Sushmita Bose Nandy
Daniel Terreros
Alok Kumar Dwivedi
Edward Saltzstein
Rajkumar Lakshmanaswamy
author_sort Arunkumar Arumugam
collection DOAJ
description Breast cancer: A protein to target for double effect A new way to treat some forms of breast cancer might be achieved by drugs that interact with a cell surface protein that binds to growth hormone and transmits growth-inducing signals into the cells. Rajkumar Lakshmanaswamy and colleagues at Texas Tech University, El Paso, USA, investigated the role of growth hormone receptor (GHR) protein in human breast cancer cells. Silencing the gene for GHR dramatically reduced the ability of the cells to multiply and spread, and also reduced the cells’ resistance to anti-cancer drugs. Increasing the activity of the GHR gene increased the cells’ cancerous activity and their resistance to chemotherapy. The research identified some molecular signaling pathways inside cells that mediated these effects. Drugs interfering with GHR activity might inhibit the spread of cancer while making existing cancer cells more susceptible to treatment.
first_indexed 2024-12-19T08:40:11Z
format Article
id doaj.art-8f0af18cfc0940eaa10f832ee755c732
institution Directory Open Access Journal
issn 1226-3613
2092-6413
language English
last_indexed 2024-12-19T08:40:11Z
publishDate 2019-01-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj.art-8f0af18cfc0940eaa10f832ee755c7322022-12-21T20:28:57ZengNature Publishing GroupExperimental and Molecular Medicine1226-36132092-64132019-01-0151111310.1038/s12276-018-0197-8Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2Arunkumar Arumugam0Ramadevi Subramani1Sushmita Bose Nandy2Daniel Terreros3Alok Kumar Dwivedi4Edward Saltzstein5Rajkumar Lakshmanaswamy6Center of Emphasis in Cancer Research, Texas Tech University Health Sciences Center El PasoCenter of Emphasis in Cancer Research, Texas Tech University Health Sciences Center El PasoCenter of Emphasis in Cancer Research, Texas Tech University Health Sciences Center El PasoResearch Core Laboratory, Texas Tech University Health Sciences Center El PasoDivision of Biostatistics & Epidemiology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El PasoUniversity Breast Care Center, Texas Tech University Health Sciences Center El PasoCenter of Emphasis in Cancer Research, Texas Tech University Health Sciences Center El PasoBreast cancer: A protein to target for double effect A new way to treat some forms of breast cancer might be achieved by drugs that interact with a cell surface protein that binds to growth hormone and transmits growth-inducing signals into the cells. Rajkumar Lakshmanaswamy and colleagues at Texas Tech University, El Paso, USA, investigated the role of growth hormone receptor (GHR) protein in human breast cancer cells. Silencing the gene for GHR dramatically reduced the ability of the cells to multiply and spread, and also reduced the cells’ resistance to anti-cancer drugs. Increasing the activity of the GHR gene increased the cells’ cancerous activity and their resistance to chemotherapy. The research identified some molecular signaling pathways inside cells that mediated these effects. Drugs interfering with GHR activity might inhibit the spread of cancer while making existing cancer cells more susceptible to treatment.https://doi.org/10.1038/s12276-018-0197-8
spellingShingle Arunkumar Arumugam
Ramadevi Subramani
Sushmita Bose Nandy
Daniel Terreros
Alok Kumar Dwivedi
Edward Saltzstein
Rajkumar Lakshmanaswamy
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
Experimental and Molecular Medicine
title Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
title_full Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
title_fullStr Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
title_full_unstemmed Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
title_short Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
title_sort silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through atp binding cassette sub family g member 2
url https://doi.org/10.1038/s12276-018-0197-8
work_keys_str_mv AT arunkumararumugam silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT ramadevisubramani silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT sushmitabosenandy silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT danielterreros silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT alokkumardwivedi silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT edwardsaltzstein silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2
AT rajkumarlakshmanaswamy silencinggrowthhormonereceptorinhibitsestrogenreceptornegativebreastcancerthroughatpbindingcassettesubfamilygmember2